130 related articles for article (PubMed ID: 29249770)
1. Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report.
Komatsu H; Izumi N; Tsukioka T; Toda M; Hara K; Miyamoto H; Nishiyama N
Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):151-153. PubMed ID: 29249770
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Renal Cell Carcinoma with High Everolimus Blood Concentrations and Hyperglycemia Due to Everolimus-Induced Hepatic Dysfunction].
Takasaki S; Kikuchi M; Kawasaki Y; Ito A; Arai Y; Yamaguchi H; Mano N
Gan To Kagaku Ryoho; 2017 Jan; 44(1):87-89. PubMed ID: 28174388
[TBL] [Abstract][Full Text] [Related]
3. Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma.
Mizuno R; Asano K; Mikami S; Nagata H; Kaneko G; Oya M
Jpn J Clin Oncol; 2012 May; 42(5):442-6. PubMed ID: 22438405
[TBL] [Abstract][Full Text] [Related]
4. Comment on "Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report".
Nomoto H; Miyoshi H; Sekizaki T; Atsumi T
Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):165-166. PubMed ID: 29553086
[No Abstract] [Full Text] [Related]
5. Evaluation of the clinical characteristics of everolimus-induced lung injury and determination of associated risk factors.
Abe M; Tsushima K; Ikari J; Kawata N; Terada J; Tanabe N; Tatsumi K
Respir Med; 2018 Jan; 134():6-11. PubMed ID: 29413509
[TBL] [Abstract][Full Text] [Related]
6. Treatment with everolimus for a patient with systemic metastatic breast cancer results in severe pulmonary injury: a case report.
Xiangying M; Tao W; Shikai W; Santai S; Zefei J
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):270-274. PubMed ID: 26932304
[TBL] [Abstract][Full Text] [Related]
7. A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma.
Saito Y; Nagayama M; Miura Y; Ogushi S; Suzuki Y; Noro R; Minegishi Y; Kimura G; Kondo Y; Gemma A
Jpn J Clin Oncol; 2013 May; 43(5):559-62. PubMed ID: 23423809
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
Yoshinaga A; Kamata S
Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
[TBL] [Abstract][Full Text] [Related]
9. [Spontaneous Remission of Everolimus-Induced Interstitial Lung Disease in Metastatic Renal Cell Carcinoma : An Autopsy Case Report].
Kurokawa M; Naito S; Ichiyanagi O; Kabasawa T; Kurota Y; Sakurai T; Nishida H; Kawazoe H; Kato T; Nagaoka A; Yamakawa M; Tsuchiya N
Hinyokika Kiyo; 2017 Sep; 63(9):377-380. PubMed ID: 28992668
[TBL] [Abstract][Full Text] [Related]
10. Everolimus-induced activation of latent
Jeon SY; Yhim HY; Lee NR; Song EK; Kwak JY; Yim CY
Korean J Intern Med; 2017 Mar; 32(2):365-368. PubMed ID: 26837008
[No Abstract] [Full Text] [Related]
11. [A case of postoperative recurrent lung cancer with long survival due to gefitinib efficacy].
Okagawa T; Uchida T; Suyama M
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1841-3. PubMed ID: 18030020
[TBL] [Abstract][Full Text] [Related]
12. A combination of preoperative CT findings and postoperative serum CEA levels improves recurrence prediction for stage I lung adenocarcinoma.
Yamazaki M; Ishikawa H; Kunii R; Tasaki A; Sato S; Ikeda Y; Yoshimura N; Hashimoto T; Tsuchida M; Aoyama H
Eur J Radiol; 2015 Jan; 84(1):178-184. PubMed ID: 25455413
[TBL] [Abstract][Full Text] [Related]
13. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
Higashi K; Sakuma T; Ito K; Niho S; Ueda Y; Kobayashi T; Sekiguchi R; Takahashi T; Kato T; Tonami H
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):373-81. PubMed ID: 18931837
[TBL] [Abstract][Full Text] [Related]
14. Relationship between CT features and high preoperative serum carcinoembryonic antigen levels in early-stage lung adenocarcinoma.
Yamazaki M; Ishikawa H; Kunii R; Tasaki A; Sato S; Ikeda Y; Yoshimura N; Aoyama H
Clin Radiol; 2014 Jun; 69(6):559-66. PubMed ID: 24625689
[TBL] [Abstract][Full Text] [Related]
15. Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease.
Nitawaki T; Sakata Y; Kawamura K; Ichikado K
BMC Pulm Med; 2017 Dec; 17(1):173. PubMed ID: 29207989
[TBL] [Abstract][Full Text] [Related]
16. Two cases of everolimus-associated interstitial pneumonia in patients with renal cell carcinoma.
Akata K; Yatera K; Ishimoto H; Kozaki M; Yamasaki K; Nagata S; Nishida C; Yoshida T; Kawanami T; Matsumoto T; Mukae H
Intern Med; 2011; 50(24):3013-7. PubMed ID: 22185995
[TBL] [Abstract][Full Text] [Related]
17. [A case of renal cell carcinoma with an extremely high serum carcinoembryonic antigen level].
Tanaka K; Chokyu H; Sugita Y; Yoshimura K; Umezu K
Hinyokika Kiyo; 1996 May; 42(5):365-7. PubMed ID: 8752540
[TBL] [Abstract][Full Text] [Related]
18. [Metastasis to the Tongue from Renal Cell Carcinoma 10 Years after Nephrectomy : A Case Report].
Wang C; Takeda K; Shiba M; Takayama H; Munakata S
Hinyokika Kiyo; 2016 Aug; 62(8):407-10. PubMed ID: 27624106
[TBL] [Abstract][Full Text] [Related]
19. Everolimus-Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE).
Kurtzman DJ; Oulton J; Erickson C; Curiel-Lewandrowski C
Dermatitis; 2016; 27(2):76-7. PubMed ID: 26983097
[No Abstract] [Full Text] [Related]
20. [A case of transitional cell carcinoma of the renal pelvis with adenocarcinoma producing CEA and CA19-9].
Matsuoka Y; Ishimaru H; Arai G; Aida J; Okada Y; Ito Y
Hinyokika Kiyo; 2004 Sep; 50(9):637-40. PubMed ID: 15518131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
